Tianjiao Li Selected Research

C 684

10/2021	Generation of a CRISPR/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene.
1/2020	Generation of a human induced pluripotent stem cell line (NCCDFWi001-A) from a Marfan syndrome patient carrying two FBN1 variants (c.2613A > C and c.684_736 + 4del).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tianjiao Li Research Topics

Disease

13	Neoplasms (Cancer) 02/2022 - 05/2017
3	Pain (Aches) 08/2022 - 10/2017
3	Chronic Pain 08/2022 - 10/2017
3	Neuralgia (Stump Neuralgia) 08/2022 - 10/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 08/2016
3	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 10/2020
3	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 12/2020 - 01/2019
2	Marfan Syndrome (Marfan's Syndrome) 10/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2017
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2019 - 01/2018
2	Adenocarcinoma 01/2019 - 01/2019
2	Hepatitis 05/2010 - 04/2010
1	Infertility (Sterility) 10/2022
1	Endometriosis 10/2022
1	Fibromyalgia (Fibrositis) 08/2022
1	Prostatic Neoplasms (Prostate Cancer) 02/2022
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2022
1	Thoracic Aorta Dissection 01/2022
1	Disease Progression 12/2021
1	Body Remains 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Urinary Retention 04/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Ataxia (Dyssynergia) 12/2020
1	Infections 07/2020
1	Fatty Liver 01/2020
1	Alcoholic Fatty Liver 01/2020
1	Dysbiosis 01/2020
1	Male Infertility (Male Sterility) 12/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2019
1	Fibrosis (Cirrhosis) 01/2019

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2016
4	Arachidonic Acid (Vitamin F)IBA 01/2021 - 08/2016
3	LipidsIBA 12/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2011
3	Therapeutic UsesIBA 09/2019 - 02/2017
2	LipopolysaccharidesIBA 01/2022 - 07/2020
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2019
2	C 684IBA 10/2021 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 02/2017
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2017
2	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 10/2020 - 04/2017
2	TanninsIBA 09/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2019
1	Long Noncoding RNAIBA 02/2022
1	Untranslated RNA (Noncoding RNA)IBA 02/2022
1	AminopropionitrileIBA 01/2022
1	thermozymocidin (myriocin)IBA 01/2022
1	CeramidesIBA 01/2022
1	MetalloproteinsIBA 01/2022
1	Ancient DNAIBA 11/2021
1	Fibrillin-1IBA 10/2021
1	Activating Transcription Factor 4IBA 10/2021
1	Ethanol (Ethyl Alcohol)IBA 10/2021
1	interleukin-21 (interleukin 21)IBA 07/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Kallikreins (Kallikrein)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Biological ProductsIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Histidine (L-Histidine)FDA Link 01/2021
1	allicinIBA 01/2021
1	purineIBA 01/2021
1	indium arsenide (InAs)IBA 12/2020
1	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 12/2020
1	Mammaglobin BIBA 10/2020
1	SecretoglobinsIBA 10/2020
1	Antimicrobial PeptidesIBA 07/2020
1	Adenosine Monophosphate (AMP)IBA 07/2020
1	ZincIBA 01/2020
1	Chemokine CXCL1IBA 01/2020
1	DefensinsIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	Circular DNAIBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Lipocalin-2IBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Circular RNAIBA 09/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	Fibronectins (Fibronectin)IBA 01/2019
1	Discoidin Domain ReceptorsIBA 01/2019
1	Laminin (Merosin)IBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019
3	Analgesia 08/2022 - 10/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 04/2017
2	Immunotherapy 01/2021 - 11/2020
1	Drug Therapy (Chemotherapy) 01/2022
1	Moxibustion 04/2021
1	Transplantation 12/2019